homospermidineplatin

N/A

Report date: 2025/03/20 15:20:29
NME

Base Information

Drug Namehomospermidineplatin
Drug Alias Namedual targeting DNA-damaging agents/apoptosis inducers (Henan University/Shandong University/Henan University of Science and Technology)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTumor protein p53 inhibitors
TargetsTumor protein p53
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesHenan University
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A